46-60 of 96
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
Project Oncology®Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
Geoffrey B. Johnson, M.D., Ph.D.
A Look at the Utility of PSMA PET Scans in Prostate Cancer
Project Oncology®A Look at the Utility of PSMA PET Scans in Prostate Cancer
Jennifer Caudle, DO, FACOFP
Geoffrey B. Johnson, M.D., Ph.D.
Disparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
NeuroFrontiersDisparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
Andrew Wilner, MD, FACP, FAAN
Victoria Leavitt, PhD
Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Project Oncology®Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Alan Bryce, MD
mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib
Project Oncology®mCRPC Care: Reducing Progression Risk by Combining Enzalutamide and Talazoparib
Charles Turck, PharmD, BCPS, BCCCP
Neeraj Agarwal, MD, FASCO
Prostate Cancer Research: Why Disparities Exist in Mortality and Trial Access
Project Oncology®Prostate Cancer Research: Why Disparities Exist in Mortality and Trial Access
Rishi Sekar, MD
- advertisement
Prostate Cancer Care: Improving Hormonal Therapy Sequencing Post-Treatment Intensification
Project Oncology®Prostate Cancer Care: Improving Hormonal Therapy Sequencing Post-Treatment Intensification
Zachery Reichert MD, PhD
The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
Project Oncology®The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
Jessica E. Hawley M.D. M.S.
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
Project Oncology®ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
Jessica E. Hawley M.D. M.S.
Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
Project Oncology®Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
Daniel Kwon, MD
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Project Oncology®Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Neal Shore, MD, FACS
Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Project Oncology®Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
- advertisement
Addressing Health Equity in Genitourinary Cancer Clinical Trials
Project Oncology®Addressing Health Equity in Genitourinary Cancer Clinical Trials
Treating mCRPC After Progression: The Potential Role of 225Ac-J591
Project Oncology®Treating mCRPC After Progression: The Potential Role of 225Ac-J591
An Exploration of Current and Emerging Therapies for mCRPC
Project Oncology®An Exploration of Current and Emerging Therapies for mCRPC
